6th ESO-EONS Masterclass in Oncology Nursing

Not eligible for ESCO credits

16.03.2013 - 21.03.2013

Ermatingen, Switzerland

MASTERCLASS

Description

Chairs: A. Margulies, CH - L. Sharp, SE
Scientific Co-ordinator: S. Faithfull, UK

The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care.

Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosocial consequences of cancer therapy.
Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant’s role in clinical leadership.

In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts.

Special joint sessions on pain control, survivorship, new oncological emergencies and oral cancer therapies will be supported by workshops and coaching to explore nursing practice in these speciality areas.

Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up.

AIMS AND OBJECTIVES
The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.

Learning outcomes:

• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate advanced communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Reflect on theoretical underpinnings of decision making .
• Describe the role of the advanced oncology nurse in leading clinical nursing care.

TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in.

All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions. Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion.

THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering advanced concepts

General information

ORGANISING SECRETARIAT
eons.secretariat@cancernurse.eu
European Oncology Nursing Society, EONS Secretariat
Att. Rudi Brike
E. Mounierlaan 83
1200 Brussels, Belgium
Phone +32 2 779 9923, Fax +32 2 779 9937

ACCREDITATION
The Masterclass programme will be accredited by the European Oncology Nursing Society.

Faculty list

FACULTY (as of November 2012)
M. Aapro, IMO - Clinique de Genolier, Department of Oncology, Genolier, CH
N. Aaronson, Antoni van Leeuwenhoek Hospital, Department of Psychosocial Research & Epidemiology, Amsterdam, NL
A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH
P. Casali, National Cancer Institute, Department of Medical Oncology, Milan, IT
A. Cervantes, Hospital Clinico Universitario, Department of Haematology and Medical Oncology, Valencia, ES
A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE
S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK
C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK
S.D. Fosså, Univesirsity of Oslo - Institute of Clinical Medicine, Oslo, NO
W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT
N. Harbeck, Uniklinik Köln, Breast Center, Cologne, DE
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK
C.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie / Hämatologie, Oldenburg, DE
P. Lorigan, University of Manchester, Institute of Cancer Sciences, Manchester, UK
J.M. Lüthi, Onkologiezentrum Thun-Berner, Thun, CH
A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH
O. Pagani, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR
G. Pichert, Cancer geneticist, CH/UK
K. Redmond, Cancer World Magazine, Lugano, CH
D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of Haemato-Oncology, Antwerp, BE
D. Sebag-Montefiore, University of Leeds, Leeds Cancer Centre, Department of Clinical Oncology, Leeds, UK
C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH
L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH
E. van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, NL
J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE
G. Viale, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT
W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH
M. Wells, University of Dundee, Dundee, UK

Programme

16 March

14:30	Greeting and introduction to Masterclass in Oncology Nursing: Aims and objectives A. Margulies, CH - L. Sharp, SE - S. Faithfull, UK
15:00	Group introduction
15:30	Role development: Advanced oncology nursing practice S. Faithfull, UK
16:15	Developing the evidence base for oncology nursing practice L. Sharp, SE
17:00	Overview of Therapy Modalities and new developments in the treatment of prostate cancer E. van Muilekom, NL
17:50	*Coffee break*
18:20	Group activity - Coaching A. Margulies, CH - L. Sharp, SE - S. Faithfull, UK
20:30	Dinner

17 March

8:30	Clinical session Gastro-intestinal tumours I Chair: D. Sebag-Montefiore, UK
	Colon cancer: Adjuvant and neoadjuvant treatment of colorectal cancer A. Cervantes, ES Systemic treatment in advanced disease C.H. Köhne, DE
10:00	*Coffee break*
10:30	Clinical session Gastro-intestinal tumours II Chair: A. Cervantes, ES
	Management of rectal cancer (surgery and radiotherapy) D. Sebag-Montefiore, UK Systemic treatment in early and advanced gastric cancer A. Cervantes, ES
12:00	Case studies 1 Presentation and discussion L. Sharp, SE
13:00	Sponsored lecture Management of senior adults with prostate cancer (SPCC lecture by Sanofi) M. Aapro, CH
13:30	Lunch
14:30	Advanced nursing assessment skills S. Faithfull, UK
15:15	Supportive care
	Cancer and pregnancy N. Pavlidis, GR Physical activity for cancer patients J.M.Lüthi, CH
16:05	*Coffee break*
16:30	New developments in radiotherapy S. Faithfull, UK
17:30	Targeted therapy - An introduction A. Margulies. CH
19:30	*Dinner*

18 March

8:30	Clinical session Breast cancer I Chair: G. Viale, IT
	What the clinician needs to know about breast pathology G. Viale, IT (Neo)Adjuvant chemotherapy and biological agents N. Harbeck, DE (Neo)Adjuvant endocrine therapy O. Pagani, CH Current controversies and challenges in breast surgery W. Gatzemeier, IT
10:15	*Coffee break*
10:45	Clinical session Breast cancer II Chair: G. Viale, IT
	Management of HER-2+ and triple negative advanced breast cancer N. Harbeck, DE Management of ER+ advanced breast cancer O. Pagani, CH
11:45	Case studies 2 Presentation and discussion L. Sharp, SE
13:15	*Lunch*
14:30	Spotlight session 3 Advances in systemic treatment of melanoma P. Lorigan, UK
15:15	Genetics and genetic counselling G. Pichert, CH/UK
16:00	Research in clinical nursing M. Wells, UK
16:45	*Coffee break*
17:15	Introduction to Communication Skills A. Hoy, UK - A. Arber, UK
18:15	Spotlight session 6 Cancer of unknown primary N. Pavlidis, GR
19:30	*Dinner*

19 March

8:30	Communication skills (Group 1) A. Hoy, UK - A. Arber, UK
8:30	Clinical session Gynaecological cancers Chair: J.B. Vermorken, BE
	Ovarian cancer J.B. Vermorken, BE Cervical and endometrial cancers C. Sessa, CH
10:30	*Coffee break*
11:00	Communication skills (Group 2) A. Hoy, UK - A. Arber, UK
11:00	Clinical session Head and neck cancer Chair: J. Bernier, CH
	Prognostic factors and surgical approach A. Dietz, DE Radiotherapy J. Bernier, CH Systemic therapy J.B. Vermorken, BE
13:00	Lunch
14:30	Market place M. Wells, UK - L. Sharp, SE - S. Faithfull, UK - E. van Muilekom, NL - A. Margulies, CH
16:00	*Free time*
19:00	*Special evening*

20 March

8:30	Clinical session Lung cancer and mesothelioma I Chair: R. Stahel, CH
	Surgery W. Weder, CH Radiotherapy C. Faivre-Finn, UK Non-small cell lung cancer systemic therapy R.A. Stahel, CH
10:30	*Coffee break*
11:00	Clinical session Lung cancer and mesothelioma II Chair: R.A. Stahel, CH
	Small cell lung cancer C. Faivre-Finn, UK Mesothelioma R.A. Stahel, CH
12:00	Case Studies 3 Presentation and discussion L. Sharp, SE
13:00	*Lunch*
14:30	Putting Evidence into Practice - guideline development - an EONS/EPAAC/ONS initiative A. Margulies, CH
15:30	Patient safety and team communication L. Sharp, SE
17:00	*Coffee break*
18:00	Learning assessment test
18:00	"Pictures speak louder than words" GROUP WORK - CLOSURE
19:30	*Dinner*

21 March

8:30	Spotlight session 7 Rare Cancers P. Casali, IT
9:30	JOINT medics and nursing session I
	Pain control - acute/chronic/breakthrough D. Schrijvers, BE Suvivorship and frequent (patient relevant) late side effects from all treatment modalities N. Aaronson, NL
10:30	Coffee break
11:00	JOINT medics and nursing session II
	“New” oncological emergencies - (new problems arising with the newer drugs) S.D. Fosså, NO Facilitating patient adherence to oral cancer therapies K. Redmond, CH
12:00	*Close*

« Back to "2013"